American journal of ophthalmology
-
Randomized Controlled Trial Comparative Study Clinical Trial
A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
Low docosahexaenoic acid (DHA) in X-linked retinitis pigmentosa (XLRP) may influence retinal function. The goals of this study were to elevate blood DHA levels and determine the effect on the rate of disease progression. ⋯ Although DHA-supplemented patients had significantly elevated mean RBC-DHA levels, the rate of cone ERG functional loss was not significantly different between groups. Supplemental analyses provided evidence for a DHA benefit and a direction for subsequent investigations.
-
Case Reports
Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
To report hypertrichosis and increased pigmentation of vellus hairs of the malar region associated with topical bimatoprost usage. ⋯ Increased hair growth in the malar region can be an early side effect of topical use of ocular bimatoprost.